Business Description
Cathay Biotech Inc
ISIN : CNE100004447
Share Class Description:
SHSE:688065: Class ACompare
Compare
Traded in other countries / regions
688065.China IPO Date
2020-08-12Description
Cathay Biotech Inc is engaged in production of revolutionary products, including bio-based polyamide,bio-based DN5 (1,5-pentanediamine), long chain dibasic acids (LCDA) and biobutanol. The company's commercial development platform focuses on research of molecular biology, fermentation process engineering, polymer material. Its products include Dibasic Acids, Pentamethylene Diamine, and Bio-based Polyamide.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.96 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.15 | |||||
| Debt-to-EBITDA | 3.18 | |||||
| Interest Coverage | 8.88 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 5.22 | |||||
| Beneish M-Score | -2.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.6 | |||||
| 3-Year EBITDA Growth Rate | 3.6 | |||||
| 3-Year EPS without NRI Growth Rate | -10.4 | |||||
| 3-Year FCF Growth Rate | -55.5 | |||||
| 3-Year Book Growth Rate | 2.4 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.02 | |||||
| 9-Day RSI | 46.58 | |||||
| 14-Day RSI | 52.03 | |||||
| 6-1 Month Momentum % | -16.29 | |||||
| 12-1 Month Momentum % | -18.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | |||||
| Quick Ratio | 2.1 | |||||
| Cash Ratio | 1.81 | |||||
| Days Inventory | 325.53 | |||||
| Days Sales Outstanding | 46.13 | |||||
| Days Payable | 302.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.36 | |||||
| Dividend Payout Ratio | 0.24 | |||||
| Forward Dividend Yield % | 0.36 | |||||
| 5-Year Yield-on-Cost % | 0.36 | |||||
| Shareholder Yield % | -1.46 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 27.61 | |||||
| Operating Margin % | 13.87 | |||||
| Net Margin % | 18.07 | |||||
| FCF Margin % | -36.65 | |||||
| ROE % | 3.72 | |||||
| ROA % | 2.23 | |||||
| ROIC % | 2.4 | |||||
| ROC (Joel Greenblatt) % | 5.92 | |||||
| ROCE % | 3.33 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 69.52 | |||||
| PE Ratio without NRI | 64.78 | |||||
| PS Ratio | 12.57 | |||||
| PB Ratio | 2.56 | |||||
| Price-to-Tangible-Book | 2.73 | |||||
| Price-to-Operating-Cash-Flow | 40.97 | |||||
| EV-to-EBIT | 48.15 | |||||
| EV-to-EBITDA | 48.15 | |||||
| EV-to-Revenue | 11.12 | |||||
| EV-to-FCF | -29.98 | |||||
| Price-to-Graham-Number | 2.8 | |||||
| Earnings Yield (Greenblatt) % | 2.08 | |||||
| FCF Yield % | -2.92 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Cathay Biotech Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,293.251 | ||
| EPS (TTM) (Â¥) | 0.71 | ||
| Beta | 1.75 | ||
| Volatility % | 38.23 | ||
| 14-Day RSI | 52.03 | ||
| 14-Day ATR (Â¥) | 1.910765 | ||
| 20-Day SMA (Â¥) | 50.9285 | ||
| 12-1 Month Momentum % | -18.03 | ||
| 52-Week Range (Â¥) | 37.5 - 67 | ||
| Shares Outstanding (Mil) | 583.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Cathay Biotech Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Cathay Biotech Inc Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Cathay Biotech Inc Frequently Asked Questions
What is Cathay Biotech Inc(SHSE:688065)'s stock price today?
The current price of SHSE:688065 is ¥49.36. The 52 week high of SHSE:688065 is ¥67.00 and 52 week low is ¥37.50.
When is next earnings date of Cathay Biotech Inc(SHSE:688065)?
The next earnings date of Cathay Biotech Inc(SHSE:688065) is .
Does Cathay Biotech Inc(SHSE:688065) pay dividends? If so, how much?
The Dividend Yield %  of Cathay Biotech Inc(SHSE:688065) is 0.36% (As of Today), Highest Dividend Payout Ratio of Cathay Biotech Inc(SHSE:688065) was 0.58. The lowest was 0.24. And the median was 0.5. The  Forward Dividend Yield % of Cathay Biotech Inc(SHSE:688065) is 0.36%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers